Q2 revenue of $22 million represents +25% growth year-over-yearPositive net income of $1 million realized with...
U.S. index futures are up in pre-market trading this Wednesday. At 6:08 AM, Dow Jones (DOWI:DJI) futures rose...
MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”...
Poster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique...
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”...
First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide...
MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”...
MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”...
Q1 2024 consolidated revenue of $16.2 million Report marks third consecutive quarter of near-flat-to-positive...
U.S. index futures are showing a mixed trend in Wednesday’s pre-market trading. Investors are eagerly...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.